Over 700 Patients Treated with Conventus Cage
Conventus Orthopaedics marked the milestone of >700 patients treated with the expandable fracture device, the Conventus Cage™. Dec 19, 2016
Stryker Orthopaedics Update on U.S. Patient Compensation
Stryker Orthopaedics reached an agreement to compensate additional eligible U.S. patients who underwent surgery to revise a Rejuvenate Modular-Neck hip stem and/or ABG II Modular-Neck hip stem prior to 12/19/16. Dec 19, 2016
Australian Joint Registry Data for DePuy’s ATTUNE Knee
Implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry confirm positive early results for DePuy Synthes’ ATTUNE® Knee. Dec 19, 2016
Amedica Re-files FDA Submission for Modified CsC-based Cervical Implant
Amedica re-filed an application with FDA with a modified cancellous-structured ceramic (CsC)-based cervical implant that is comparable to the Valeo®C. Dec 19, 2016
Vericel’s Proposed Public Offering of Common Stock
Vericel intends to sell shares of common stock in an underwritten public offering. Dec 16, 2016
Safe Orthopaedics Receives CE Mark for Oak Pedicle Screw
Safe Orthopaedics received approval under the CE Mark for a next-generation Oak pedicle screw for the treatment of thoracic vertebral fractures. Dec 16, 2016
Study Results: InSpace in the Treatment of Massive Rotator Cuff Tears
Initial study results indicate that patients undergoing the InSpace™ procedure to treat massive rotator cuff tears experienced durable improvements in shoulder function and reductions in shoulder pain at one year. Dec 16, 2016
2016: The Year in Products and Services
Editor’s Note: “Keep me informed on what everyone is doing” is, without fail, one request returned in every ORTHOWORLD Membership... Dec 15, 2016
Study Results: OrthoTrophix TPX-100 in Knee OA
OrthoTrophix announced results of the first proof of principle study of TPX-100 in bilateral knee osteoarthritis, showing improvements at 6 and 12 months in key knee-related outcome measures. Dec 15, 2016
SpinalCyte’s IRB Approval for Phase I Clinical Trial
SpinalCyte received IRB approval to commence Phase I clinical trials with its CybroCell dermal fibroblast cell product in the treatment of degenerative disc disease. Dec 15, 2016
